Date Title Division/Office
Division of Corporation Finance Statement Regarding Requirements for Form 144 Paper Filings in Light of COVID-19 Concerns Corporation Finance
Staff Guidance for Conducting Shareholder Meetings in Light of COVID-19 Concerns Corporation Finance
CF Disclosure Guidance Topic: Coronavirus (COVID-19) Corporation Finance
Coronavirus (COVID-19) Corporation Finance
Staff Statement Regarding Rule 302(b) of Regulation S-T in Light of COVID-19 Concerns Corporation Finance
Division of Corporation Finance Operating Status Corporation Finance
Statement on Continued Dialogue with Audit Firm Representatives on Audit Quality in China and Other Emerging Markets; Coronavirus — Reporting Considerations and Potential Relief Corporation Finance
CF Disclosure Guidance Topic: Confidential Treatment Applications Submitted Pursuant to Rules 406 and 24b-2 Corporation Finance
CF Disclosure Guidance Topic: Intellectual Property and Technology Risks Associated with International Business Operations Corporation Finance
Disclosure Program Realignment Corporation Finance
Announcement Regarding Rule 14a-8 No-Action Requests Corporation Finance
New Rules and Procedures for Exhibits Containing Immaterial, Competitively Harmful Information Corporation Finance
Division of Corporation Finance Staff to Continue to Enhance Transparency of Staff Actions Corporation Finance
Division to Release through EDGAR Serious Deficiencies Letters Corporation Finance
False Telephone Communications Claiming to Be from the SEC Corporation Finance
Exchange Act Forms Corporation Finance
Waivers of Disqualification under Regulation A and Rules 505 and 506 of Regulation D Corporation Finance
Draft Registration Statement Processing Procedures Expanded Corporation Finance
"Tandy" Representations No Longer Needed in Filing Reviews Corporation Finance
Opportunity for Issuers to Receive Feedback on Test Filings in Preparation for Asset-Backed Securities Offerings That Require Asset-Level Data Corporation Finance

Last Reviewed or Updated: June 28, 2024